Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization

Br J Haematol. 2013 Jan;160(2):153-70. doi: 10.1111/bjh.12091. Epub 2012 Nov 15.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Blood Coagulation Factors / therapeutic use
  • Blood Loss, Surgical / prevention & control
  • Clinical Trials as Topic
  • DNA Mutational Analysis
  • Desensitization, Immunologic
  • Dose-Response Relationship, Immunologic
  • Factor IX / antagonists & inhibitors*
  • Factor IX / genetics
  • Factor IX / immunology
  • Factor IX / therapeutic use
  • Factor VIII / antagonists & inhibitors*
  • Factor VIII / genetics
  • Factor VIII / immunology
  • Factor VIII / therapeutic use
  • Factor VIIa / therapeutic use
  • Female
  • Hemophilia A / genetics
  • Hemophilia A / immunology*
  • Hemophilia A / therapy
  • Hemophilia B / genetics
  • Hemophilia B / immunology*
  • Hemophilia B / therapy
  • Hemorrhage / drug therapy
  • Hemorrhage / prevention & control
  • Humans
  • Immune Tolerance
  • Immunologic Tests / methods
  • Immunosuppressive Agents / therapeutic use
  • Isoantibodies / biosynthesis
  • Isoantibodies / blood
  • Isoantibodies / immunology*
  • Male
  • Recombinant Proteins / therapeutic use
  • Risk Factors
  • State Medicine / organization & administration
  • United Kingdom

Substances

  • Blood Coagulation Factors
  • Immunosuppressive Agents
  • Isoantibodies
  • Recombinant Proteins
  • Factor VIII
  • Factor IX
  • recombinant FVIIa
  • anti-inhibitor coagulant complex
  • Factor VIIa